Professional Resources

As internationally known leaders in valvular heart disease, our team of physicians shares their research findings through presentations, digital resources, publications, and more.  

Accelerating Research through MHIF's International Scholar Program

Research Scholar, Valve Science Center
The Valve Science Center team hosts full-time research scholars for a period of at least two years. Scholars develop significant expertise in designing and executing clinical studies, and previous scholars in the program have been very successful in publishing and securing clinical residency/fellowship training positions. More information


Research in Action

MHIF Valve Science Center physicians from the Minneapolis Heart Institute® are renowned leaders across all disciplines. Accomplishments from our world-class research physician partners include:

Grand Rounds

The Valve Science Center is a key and regular contributor to Grand Rounds, our physician and healthcare professional education program. 

Tricuspid Valve Management


Clinical Impact of "Moderate" Aortic Stenosis and the Potential Benefit of Therapy

Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.